Literature DB >> 3285783

Atrial fibrillation: natural history, complications, and management.

J S Alpert1, P Petersen, J Godtfredsen.   

Abstract

Atrial fibrillation is a clinically important arrhythmia that carries important prognostic and therapeutic implications. Hypertension, ischemic heart disease, and rheumatic valvular disease are the commonest causes of atrial fibrillation. The presence of chronic or paroxysmal atrial fibrillation places the patient at increased risk for embolic stroke and/or death. When atrial fibrillation develops, there is loss of the atrial transport factor ("atrial kick"), with consequent decrease of cardiac output. Stroke output declines by 20-30% in normal individuals with loss of atrial kick; the decline in stroke output is considerably larger in patients with heart disease. Atrial fibrillation can be electrically or pharmacologically reverted to sinus rhythm. Even patients with refractory atrial fibrillation can be reverted to sinus rhythm with amiodarone.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3285783     DOI: 10.1146/annurev.me.39.020188.000353

Source DB:  PubMed          Journal:  Annu Rev Med        ISSN: 0066-4219            Impact factor:   13.739


  28 in total

1.  Prospective randomized trial of external versus internal transcatheter cardioversion in patients with chronic atrial fibrillation.

Authors:  K E Paravolidakis; T M Kolettis; G N Theodorakis; I A Paraskevaidis; T S Apostolou; D T Kremastinos
Journal:  J Interv Card Electrophysiol       Date:  1998-09       Impact factor: 1.900

Review 2.  New-onset atrial fibrillation: an update.

Authors:  Takeshi Omae; Eiichi Inada
Journal:  J Anesth       Date:  2018-03-09       Impact factor: 2.078

Review 3.  Atrial Septal Defect and Atrial Fibrillation: The Known and Unknown.

Authors:  George E Blake; Dhanunjaya Lakkireddy
Journal:  J Atr Fibrillation       Date:  2008-09-16

4.  Inhibitory effects of aprindine on the delayed rectifier K+ current and the muscarinic acetylcholine receptor-operated K+ current in guinea-pig atrial cells.

Authors:  Y Ohmoto-Sekine; H Uemura; M Tamagawa; H Nakaya
Journal:  Br J Pharmacol       Date:  1999-02       Impact factor: 8.739

5.  Predictive value of heart rate variability for the recurrence of chronic atrial fibrillation after electrical cardioversion.

Authors:  Omer Akyürek; Erdem Diker; Muharrem Güldal; Derviş Oral
Journal:  Clin Cardiol       Date:  2003-04       Impact factor: 2.882

6.  Capability of a new paediatric oesophageal Doppler monitor to detect changes in cardiac output during testing of external pacemakers after cardiac surgery.

Authors:  Thilo Fleck; Stephan Schubert; Brigitte Stiller; Matthias Redlin; Peter Ewert; Nicole Nagdyman; Felix Berger
Journal:  J Clin Monit Comput       Date:  2011-11-12       Impact factor: 2.502

7.  Physician variation in the management of patients with atrial fibrillation.

Authors:  G Y Lip; J Zarifis; R D Watson; D G Beevers
Journal:  Heart       Date:  1996-02       Impact factor: 5.994

Review 8.  Maintaining stability of sinus rhythm in atrial fibrillation: antiarrhythmic drugs versus ablation.

Authors:  Gerald V Naccarelli; John Hynes; Deborah L Wolbrette; Luna Bhatta; Mazhar Khan; Jerry Luck
Journal:  Curr Cardiol Rep       Date:  2002-09       Impact factor: 2.931

9.  Inhibition of platelet-derived growth factor-AB signaling prevents electromechanical remodeling of adult atrial myocytes that contact myofibroblasts.

Authors:  Hassan Musa; Kuljeet Kaur; Ryan O'Connell; Matt Klos; Guadalupe Guerrero-Serna; Uma Mahesh R Avula; Todd J Herron; Jerômé Kalifa; Justus M B Anumonwo; José Jalife
Journal:  Heart Rhythm       Date:  2013-03-14       Impact factor: 6.343

Review 10.  There goes the neighborhood: pathological alterations in T-tubule morphology and consequences for cardiomyocyte Ca2+ handling.

Authors:  William E Louch; Ole M Sejersted; Fredrik Swift
Journal:  J Biomed Biotechnol       Date:  2010-04-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.